• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anuh Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 2916.0
  • ISIN : INE489G01022
167.53 -6 (-3.46%)
  • As on 01 May 2025 (EOD)
  • Today’s Low

    167.10
  • Today’s High

    173.15
  • Open

    173.15
  • Perv Close

    173.54
  • 52W Low

    148.50
  • 52W High

    245.70

Key Indicators

  • P/E(TTM)

    16.70

  • Mar.Cap (₹Cr.)

    839.53

  • Div & Yield %

    1.49

  • Book Value(₹)

    60.49

  • Debt-Equity Ratio

    -3.46

  • AGM Date

    30-Apr-2025

  • EPS

    10.03

  • P/E Ratio

    16.70

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    839.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    25.06

  • BV (₹)

    60.50

  • Sales( ₹ in Cr.)

    647.00

  • NP (in Cr.)

    51.88

  • NP Var(%)

    58.0

  • Div%

    50.0

  • CPS (₹)

    12.10

  • EPS (₹)

    10.40

  • Traded Value (₹ in Lakhs)

    839.63

  • 52 Week High

    245.70

  • 52 Week Low

    148.50

  • Price BSE

    168.0

  • Price NSE

    168.00

  • Market Capital( in Cr.)

    839.63

  • P/C Ratio

    13.90

  • P/E Ratio

    16.20

  • Price Vs.BV

    10.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 647.00 527.49 486.65 431.96 306.96 320.66
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 647.00 527.49 486.65 431.96 306.96 320.66
Other Income 12.10 6.11 5.20 10.54 4.21 4.70
Stock Adjustments 15.24 -13.48 4.86 -2.31 13.51 6.22
Total Income 674.34 520.12 496.71 440.19 324.68 331.58
EXPENDITURE :            
Raw Materials 501.90 388.00 382.54 327.49 243.67 249.16
Power and Fuel Cost 12.37 11.02 8.80 8.66 6.31 4.79
Employee Cost 19.39 17.15 15.10 14.29 13.36 10.14
Other Manufacturing Expenses 23.72 19.98 14.91 13.41 11.97 12.65
Selling and Administration Expenses 15.50 13.28 12.07 11.17 8.90 9.98
Miscellaneous Expenses 13.61 12.77 10.62 9.51 13.02 10.21
Employee Benefit Expenses 19.39 17.15 15.10 14.29 13.36 10.14
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 586.49 462.20 444.04 384.53 297.23 296.92
Operating Profit 87.85 57.92 52.66 55.66 27.45 34.66
Interest 0.96 0.75 1.58 2.03 1.26 0.60
Gross Profit 86.89 57.17 51.08 53.63 26.19 34.06
Depreciation 8.58 9.70 11.96 15.08 7.03 1.66
Profit Before Tax 78.31 47.47 39.12 38.55 19.16 32.40
Current Tax 18.13 12.12 10.58 9.47 3.54 8.79
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.12 -0.83 -2.02 0.65 1.31 0.25
Reported Net Profit 60.06 36.18 30.56 28.44 14.31 23.37
Extraordinary Items 8.17 3.24 1.97 5.94 1.06 1.38
Adjusted Net Profit 51.89 32.94 28.59 22.50 13.25 21.99
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.06
P & L Balance brought forward 113.59 93.18 76.14 53.70 56.01 47.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 17.02 15.77 13.52 6.00 16.61 14.31
P & L Balance carried down 156.63 113.59 93.18 76.14 53.70 56.01
Dividend 0.00 0.00 0.00 0.00 6.89 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 50.00 40.00 35.00 30.00 55.00 55.00
Dividend Per Share(Rs) 2.50 2.00 1.75 1.50 2.75 2.75
Earnings Per Share-Unit Curr 11.98 7.22 6.10 5.67 5.71 9.33
Earnings Per Share(Adj)-Unit Curr 11.98 7.22 6.10 5.67 2.86 4.67
Book Value 58.11 48.14 42.66 38.04 64.74 65.69
Book Value(Adj)-Unit Curr 58.11 48.14 42.66 38.04 32.37 32.85

Shareholding Pattern

  • Promoter Group

    69.92%

  • Public Share Holding

    30.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 7,200 7,200.00 7,200 7,200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 7,200 0.01 7,200 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,685,684 37.29 18,685,684 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 16,343,574 32.61 16,343,574 21
Sub Total 35,029,258 69.90 35,029,258 31
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 150 0.00 150 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 18,059 0.04 18,059 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 18,209 0.04 18,209 4
2] Non Institution
Bodies Corporate 436,239 0.87 407,439 86
Clearing Members 18,455 0.04 18,455 10
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 968,182 1.93 968,182 421
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 583,442 1.16 583,442 518
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,225,653 6.44 3,168,053 34
Individuals holding nominal share capital up to Rs. 1 lakh 9,763,087 19.48 9,643,427 23,126
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 62,275 0.12 62,275 4
Sub Total 15,057,333 30.05 14,851,273 24,199
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,112,000 100.00 49,905,940 24,235

Company Background

Anuh Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Anuh Pharma Ltd
  • BSE Code : 2916.0
  • ISIN : INE489G01022
  • Incorporation Year

    1960

  • Registered Office

    3-A Shivsagar Estate
    North Wing Dr A B Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-6622 7575

  • FAX

    91-22-6622 7600

  • Chairman

    Arun L Todarwal

  • Managing Director

    Ritesh B Shah

  • Company Secretary

    Manan Jayesh Vadhan

  • Auditor

    Jayantilal Thakkar & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    BigShare Services Pvt Ltd
    J/12 Ansa Indl Est,
    Sakivihar Road,Sakinaka Andheri (E)
    Mumbai - Mumbai - 400072

Anuh Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anuh Pharma 167.55 659.10 647.00 16.70 25.44
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92